aid: profusa
name: Profusa
description: 'Profusa, Inc. (Nasdaq: PFSA) is a South San Francisco digital-health and
  medical-device company that builds tissue-integrated biosensors — injectable, biologically
  compatible hydrogel microsensors smaller than a grain of rice — for continuous, real-time
  monitoring of body chemistry. Its Lumee Oxygen Platform reports tissue oxygen for
  peripheral artery disease, chronic wounds and reconstructive surgery, and a long-duration
  Lumee glucose sensor is in development. A companion Data Platform turns raw sensor
  readings into clinical intelligence for clinicians, with EMR integration described as
  planned rather than shipped. Profusa has received more than USD 23M in NIH and DARPA
  funding and became publicly traded in July 2025 through a business combination with
  NorthView Acquisition Corporation. As of this profiling pass the company publishes no
  developer program, no public API documentation and no machine-readable API contract.'
url: https://raw.githubusercontent.com/api-evangelist/profusa/refs/heads/main/apis.yml
x-api-posture: no-product-api
x-api-posture-basis: observed
x-api-posture-note: "As of this profiling pass the company publishes no developer program, no public API documentation and no machine-readable API contract."
deliveryModel:
  model: unknown
  open_source: false
  commercial: false
  callable_host: false
  label: Delivery model not determined — needs a product licence on record
  confidence: low
  source:
  - none
  generated: '2026-08-28'
  method: derived
image: https://profusa.com/wp-content/uploads/2015/12/cropped-profusa-logo-1-270x270.png
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-26'
modified: '2026-08-26'
tags:
- Company
- Health
- Medical Devices
- Biosensors
- Digital Health
- Continuous Monitoring
- Diagnostics
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/profusa-domain-security.yml
- type: Website
  url: https://profusa.com/
- type: About
  url: https://profusa.com/about-profusa/
- type: Support
  url: https://profusa.com/contact-profusa/
- type: Blog
  url: https://investors.profusa.com/press-releases
- type: BlogRSS
  url: https://profusa.com/feed/
- type: Careers
  url: https://profusa.com/careers-profusa/
- type: InvestorRelations
  url: https://investors.profusa.com/
- type: LinkedIn
  url: https://www.linkedin.com/company/profusa
- type: LLMsTxt
  url: llms/profusa-llms.txt
x-enrichment:
  date: '2026-08-26'
  status: minimal
  artifacts_added: 3
  pass: local-v1
x-coverage:
  state: none
  reason: no-developer-program
  detail: >-
    Profusa ships a clinical Data Platform and a phone app for its Lumee biosensors but
    publishes nothing for developers — profusa.com is a WordPress marketing site whose
    only machine-readable surface is the generic WordPress core REST discovery document
    at /wp-json/, and every developer path (/developers, /api, /docs, /openapi.json,
    /llms.txt, /.well-known/*) returns 404, while investors.profusa.com answers 200 with
    an SPA shell for every path including /.well-known/agent-card.json.
  evidence:
  - url: https://profusa.com/developers
    status: 404
  - url: https://profusa.com/openapi.json
    status: 404
  - url: https://profusa.com/llms.txt
    status: 404
  - url: https://profusa.com/.well-known/agent-card.json
    status: 404
  - url: https://profusa.com/wp-json/
    status: 200
  - url: https://investors.profusa.com/.well-known/agent-card.json
    status: 200
  checked: '2026-08-26'